Ocuphire Pharma, Inc.

( )
OCUP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. -0.62%51.400.9%$2116.73m
JNJJohnson & Johnson 0.62%164.370.7%$1382.14m
MRKMerck & Co., Inc. 1.25%73.180.7%$1043.36m
BMYBristol-Myers Squibb Co. 0.81%57.591.0%$831.23m
LLYEli Lilly & Co. -0.35%244.251.1%$718.99m
ABBVAbbVie, Inc. 0.31%121.891.9%$627.54m
AZNAstraZeneca Plc 0.68%55.131.0%$309.49m
NVSNovartis AG 0.83%81.350.2%$178.86m
GSKGlaxoSmithKline Plc 0.70%42.680.2%$161.90m
DRNADicerna Pharmaceuticals, Inc. -0.42%38.000.3%$157.34m
VTRSViatris, Inc. 0.24%12.430.0%$141.06m
BFRIBiofrontera, Inc. 12.13%4.900.0%$131.89m
RPRXRoyalty Pharma Plc 1.58%39.160.1%$121.97m
RGENRepligen Corp. 2.85%266.036.7%$99.58m
NVONovo Nordisk A/S 2.96%113.420.1%$88.62m

Company Profile

Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.